Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2017-01-31
2019-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
H0: Cupping therapy has no effect on improving pain, ROM, functionality and quality of life in individuals with RCI.
H1: Cupping therapy has an effect on improving pain, ROM, functionality and quality of life in individuals with RCI.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Dry Cupping Therapy Group
In addition to the conventional treatment, moving cup application was applied for 10 minutes twice a week. During the treatment, the patients were placed in a side-lying position with the affected side on top. Liquid petroleum jelly was applied on the skin and negative pressure was created with a manual pump, allowing the cup to be slid on the skin. Care was taken to ensure that the negative pressure would not cause increased pain and would allow the cup to slide. Deltoid, Trapeze, Supraspinatus, Infraspinatus, Pectoral muscles were applied in the origo insertion direction for a total of 10 minutes.
Dry Cupping Therapy
Conservative Treatment (hotpack, transcutaneous electrical nerve stimulation(TENS), ultrasound
Conservative Treatment Group
The patients in the control group received a conservative treatment program including hotpack (20 min), transcutaneous electrical nerve stimulation(TENS) (COMPEX Rehab 400 - 20 min), ultrasound (Chattanooga Ultrasound - 1 megahertz, 1.5 W/cm², 5 min) for 4 weeks, 5 days a week, and wand, Codman, stretching and strengthening exercises were applied.Stretching exercises were added to the treatment for the shoulder girdle and scapular region muscles, while strengthening exercises were added to the treatment by increasing the resistance at the pain limit. In addition, the home exercise program was taught to be 10 repetitions 2 times a day.
Conservative Treatment (hotpack, transcutaneous electrical nerve stimulation(TENS), ultrasound
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dry Cupping Therapy
Conservative Treatment (hotpack, transcutaneous electrical nerve stimulation(TENS), ultrasound
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Clinical diagnosis ofRCI, SIS, supraspinatus tendinitis
* To be fully cooperative
Exclusion Criteria
* A history of shoulder fracture
* Severe osteoporosis
* Total tendon rupture
* Had received oral/intramuscular steroids in the last 1 month
* Had been administered intra-articular drugs in the last 3 months
* Difficulty in cooperation
25 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Istanbul Medipol University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
sumeyye tunc
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Esra ATILGAN
Role: STUDY_DIRECTOR
Medipol University
Hatice Hümeyra AKIL
Role: PRINCIPAL_INVESTIGATOR
Uskudar University
Sümeyye TUNÇ
Role: STUDY_CHAIR
Medipol University
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IMU-FTR-ST-02
Identifier Type: -
Identifier Source: org_study_id